Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma.
Bayles I, Krajewska M, Pontius WD, Saiakhova A, Morrow JJ, Bartels C, Lu J, Faber ZJ, Fedorov Y, Hong ES, Karnuta JM, Rubin B, Adams DJ, George RE, Scacheri PC.
Bayles I, et al. Among authors: pontius wd.
J Clin Invest. 2019 Oct 1;129(10):4377-4392. doi: 10.1172/JCI127718.
J Clin Invest. 2019.
PMID: 31498151
Free PMC article.